… preceded the full understanding of the mechanism of action and the identification of …
Controlled vocabulary supplemented with keywords was used to search for lung cancer, erlotinib …

… augmentative tumor growth inhibitory effect between erlotinib … reduction in cell viability by
erlotinib in lung cancer cells. This … and curcumin although the cell lines used were different (Su …

… efficacy outcomes in patients with non-small cell lung cancer (NSCLC). Erlotinib prolonged
overall survival (OS) versus … The impact of patient characteristics on clinical outcomes with …

… The effects of erlotinib appeared later with longer remission. It seems that suppressing tumor
cells rather killing tumor cells is the main effect of erlotinib. Therefore, we consider that it is …

… Lung cancer is the leading cause of cancer-related deaths … -small cell lung cancer (NSCLC,
>85 % of lung cancer) present … that bevacizumab affects the antitumor activity of erlotinib and …

… ® Survival Evaluation in Lung Cancer (ISEL), that investigated the effect of gefitinib on survival
… response to erlotinib in the BR.21 study, erlotinib had a significant effect on survival in all …

… The use of erlotinib in first-line did not seem to have a detrimental effect on the response to
subsequent chemotherapy. Our results are similar to those obtained with first-line gefitinib in …

… erlotinib showed strong synergistic inhibitory effects on cell … the effects of erlotinib in both
EGFR-TKI-resistant cells in vitro … -TKI-resistant NSCLC cell lines (Supporting Information Table …

… -cell lung cancer (NSCLC) is the leading cause of cancer-… -TKI), such as erlotinib or gefitinib,
demonstrated efficacy in … In this article, the authors analyzed data of erlotinib in NSCLC…

… We examined the effects of tunicamycin and erlotinib on cytotoxicity of erlotinib-sensitive
and resistant NSCLC cell lines, as well its effects on apoptotic pathways and on EGFR …